Invectys

Pre-clinical

Paris, FranceFounded 2010invectys.com

Develops immunotherapies targeting cancer antigens for oncology treatments.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $37.5M

Develops immunotherapies targeting cancer antigens for oncology treatments.

RNA & Gene Therapy

Total raised:$37.5M

Grant$2.5MEuropean CommissionMar 15, 2021

Series B$25MUndisclosedSep 15, 2019

Series A$10MUndisclosedMay 15, 2016